Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
43,695,110
-
Shares change
-
+3,056,602
-
Total reported value, excl. options
-
$1,891,593,236
-
Value change
-
+$132,687,661
-
Put/Call ratio
-
103%
-
Number of buys
-
83
-
Number of sells
-
-90
-
Price
-
$43.29
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q2 2016
226 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q2 2016.
BLUEBIRD BIO INC - COM (BLUE) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,695,110 shares
.
Largest 10 shareholders include FMR LLC (5,541,457 shares), BAILLIE GIFFORD & CO (5,054,175 shares), Capital Research Global Investors (4,523,635 shares), VANGUARD GROUP INC (2,680,871 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,444,381 shares), WELLINGTON MANAGEMENT GROUP LLP (2,075,954 shares), STATE STREET CORP (1,699,977 shares), BlackRock Fund Advisors (1,386,229 shares), OppenheimerFunds, Inc. (1,352,334 shares), and ORBIMED ADVISORS LLC (1,185,800 shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.